Curaleaf plans 1-for-3 reverse stock split ahead of potential US exchange listing

INVESTING.COMMay 26, 11:52 AM UTC

Key insights

  • Curaleaf announced a 1-for-3 reverse stock split to meet listing requirements for a major US exchange, driven by potential cannabis rescheduling. This aims to increase share price and attract institutional investors. While positive sentiment, actual uplisting and regulatory changes are uncertain, limiting immediate market impact. The move signals confidence in future US market access.
Curaleaf plans 1-for-3 reverse stock split ahead of potential US exchange listing

Curaleaf Holdings, Inc. (CURA) announced a 1-for-3 reverse stock split of its subordinate voting shares, effective June 5, 2026. The cannabis company’s board approved the consolidation to meet share price requirements for potential listing on a major US stock exchange.

The reverse split will reduce Curaleaf’s outstanding shares from approximately 698.7 million to about 232.9 million shares. The company stated the action was taken in consultation with major US stock exchanges and aims to increase the trading price per share to meet exchange listing criteria.

"This important step is part of Curaleaf’s long-term effort to achieve the listing of our shares to a major US stock exchange," said Boris Jordan, chairman and CEO. He cited recent cannabis rescheduling developments as creating a potential pathway for uplisting to a US exchange.

The reverse split has received conditional approval from the Toronto Stock Exchange, where Curaleaf’s shares will continue trading under the symbol "CURA" following the consolidation. The company also trades on the OTCQX market under the symbol CURLF.

Registered shareholders will receive letters of transmittal requiring them to exchange their existing share certificates through transfer agent Odyssey Trust Company. Shareholders holding shares through brokers will not need to complete this process. The exercise price and share quantities for outstanding stock options and convertible securities will be adjusted proportionately.

Curaleaf operates as an international cannabis product provider with operations across North America, Europe and Australasia. The company filed its latest annual information form on February 26, 2026, according to the press release.

Continue reading on INVESTING.COM

Related Articles